Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Esomeprazole in Patients With Frequent Heartburn

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and non-pregnant ,non-lactating females 18 years or older~* Experience heartburn at least 2 days a week~* Having heartburn that has responded to heartburn medication~* Must discontinue any current heartburn medications~Exclusion Criteria:~* Having a history of erosive esophagitis verified by endoscopy~* Having a history of GERD which was diagnosed by a physician~* Inability to take study medication or complete the study and all study procedures~* Subjects that have required more than one 14-day course of PPI treatment within the past 4 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Esomeprazole 20 mg (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).